BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34497200)

  • 21. BCR/ABL1-like acute lymphoblastic leukemia: How to diagnose and treat?
    Chiaretti S; Messina M; Foà R
    Cancer; 2019 Jan; 125(2):194-204. PubMed ID: 30561755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
    Mullighan CG
    Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia.
    Hunger SP
    Hematology Am Soc Hematol Educ Program; 2011; 2011():361-5. PubMed ID: 22160058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Philadelphia-like acute lymphoblastic leukemia: diagnostic dilemma and management perspectives.
    Kotb A; El Fakih R; Hanbali A; Hawsawi Y; Alfraih F; Hashmi S; Aljurf M
    Exp Hematol; 2018 Nov; 67():1-9. PubMed ID: 30075295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics.
    Schwab C; Harrison CJ
    Hemasphere; 2018 Aug; 2(4):e53. PubMed ID: 31723781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Down syndrome and acute lymphoblastic leukemia].
    Okamoto Y
    Rinsho Ketsueki; 2021; 62(10):1465-1473. PubMed ID: 34732618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening of adult Ph-like acute lymphoblastic leukemia by multiplex real-time quantitative PCR].
    Xu MZ; Fang QY; Gong XY; Feng J; Jia YJ; Li QH; Liu KQ; Zhao XL; Ru K; Tian Z; Tang KJ; Wang M; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):956-961. PubMed ID: 29224319
    [No Abstract]   [Full Text] [Related]  

  • 28.
    Jain S; Abraham A
    Arch Pathol Lab Med; 2020 Feb; 144(2):150-155. PubMed ID: 31644323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.
    Roberts KG; Gu Z; Payne-Turner D; McCastlain K; Harvey RC; Chen IM; Pei D; Iacobucci I; Valentine M; Pounds SB; Shi L; Li Y; Zhang J; Cheng C; Rambaldi A; Tosi M; Spinelli O; Radich JP; Minden MD; Rowe JM; Luger S; Litzow MR; Tallman MS; Wiernik PH; Bhatia R; Aldoss I; Kohlschmidt J; Mrózek K; Marcucci G; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Paietta E; Willman CL; Mullighan CG
    J Clin Oncol; 2017 Feb; 35(4):394-401. PubMed ID: 27870571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.
    Imamura T; Kiyokawa N; Kato M; Imai C; Okamoto Y; Yano M; Ohki K; Yamashita Y; Kodama Y; Saito A; Mori M; Ishimaru S; Deguchi T; Hashii Y; Shimomura Y; Hori T; Kato K; Goto H; Ogawa C; Koh K; Taki T; Manabe A; Sato A; Kikuta A; Adachi S; Horibe K; Ohara A; Watanabe A; Kawano Y; Ishii E; Shimada H
    Blood Cancer J; 2016 May; 6(5):e419. PubMed ID: 27176795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises.
    Izraeli S
    Curr Opin Hematol; 2014 Jul; 21(4):289-96. PubMed ID: 24848770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
    Schwartzman O; Savino AM; Gombert M; Palmi C; Cario G; Schrappe M; Eckert C; von Stackelberg A; Huang JY; Hameiri-Grossman M; Avigad S; Te Kronnie G; Geron I; Birger Y; Rein A; Zarfati G; Fischer U; Mukamel Z; Stanulla M; Biondi A; Cazzaniga G; Vetere A; Wagner BK; Chen Z; Chen SJ; Tanay A; Borkhardt A; Izraeli S
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E4030-E4039. PubMed ID: 28461505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research Progress on Pathogenic Genes of Ph-like Acute Lymphoblastic Leukemia--Review].
    Li ZZ; Wang YJ; Feng JK; Tan JB; Zhao RB; Yang TH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):695-699. PubMed ID: 32319419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.
    Iacobucci I; Roberts KG
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34062932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
    Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
    Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.
    Kaczmarska A; Śliwa P; Zawitkowska J; Lejman M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements.
    Tanasi I; Ba I; Sirvent N; Braun T; Cuccuini W; Ballerini P; Duployez N; Tanguy-Schmidt A; Tamburini J; Maury S; Doré E; Himberlin C; Duclos C; Chevallier P; Rousselot P; Bonifacio M; Cavé H; Baruchel A; Dombret H; Soulier J; Landman-Parker J; Boissel N; Clappier E
    Blood; 2019 Oct; 134(16):1351-1355. PubMed ID: 31434701
    [No Abstract]   [Full Text] [Related]  

  • 38. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
    De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
    Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options.
    Khan M; Siddiqi R; Tran TH
    Semin Hematol; 2018 Oct; 55(4):235-241. PubMed ID: 30502852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia.
    Mohamed SMA; Wohlmann A; Schofield P; Sia KCS; McCalmont H; Savvides SN; Verstraete K; Kavallaris M; Christ D; Friedrich KH; Bayat N; Lock RB
    Int J Biol Macromol; 2021 Nov; 190():214-223. PubMed ID: 34481852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.